Other
General Surgery
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
General Surgery is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
7
clinical trials
Completed3 · 43%
Unknown status1 · 14%
Not yet recruiting1 · 14%
Withdrawn1 · 14%
Enrolling by invitation1 · 14%
Clinical Trials
Trial Activity
7 trials
Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?
Not yet recruiting·—·Phase 4·NCT06505148·80 enrolled
Irrisept in Emergency General Surgery Patients
Enrolling by invitation·TThe University of Texas Health Science Center at Tyler·Phase 4·NCT07048899·400 enrolled
A Study of the Effects of Intravenous Magnesium Sulphate on Anaesthesia and Analgesia in Elective General Surgery Patients
Unknown status·—·N/A·NCT05598307·90 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)